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COMMENTARY
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carcinogenesis
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Institute of Toxicology, Swiss Federal Institute of Technology and
University of Zurich, CH-8603 Schwerzenbach, Switzerland
Data supporting various dose-response relationships in
chemical carcinogenesis are summarized. General principles
are derived to explain the relationships between exposure
dose, DNA adduct level, induction of genetic changes, and
tumor incidence. Some mechanistic aspects of epigenetic
carcinogens (stimulation of cell division and maldifferentia-
tion) are analyzed in a similar way. In a homogeneous popula-
tion, non-linearities are frequent. They are due to phenomena
of induction or saturation of enzymatic activities and to the
multi-step nature of carcinogenesis: if a carcinogen accelerates
more than one step, the superposition of the dose—response
curves for the individual steps can result in an exponential
relationship. A fourth power of the dose was the maximum
seen in animals (formaldehyde). At the lowest dose levels, a
proportionality between dose and tumor induction is
postulated independent of the mechanism of action if the
carcinogen accelerates the endogenous process responsible for
spontaneous tumor formation. Low-dose thresholds are
expected only for situations where the carcinogen acts in a
way that has no endogenous counterpart. Epidemiological
studies in humans show linear dose-response curves in all
but two investigations. The difference from the strongly non-
linear slopes seen in animal studies could be due to the
heterogeneity of the human population: if the individual
sensitivity to a carcinogen is governed by a large number of
genetic and life-style factors, the non-linearities will tend to
cancel each other out and the dose-response curve becomes
'quasi-linear'.
Introduction
The problem of low-dose extrapolation
Whenever a chemical to which humans can be exposed has been
found to be carcinogenic in animals, the question arises as to
an acceptable dose level. In view of a tumor incidence of
30-40% in humans (cumulative for a 75-year life span in white
females and males respectively), an increase by one additional
tumor in a million exposed is often considered a 'virtually safe'
dose. Since an increase of the tumor incidence in an animal
bioassay must be of the order of at least a few per cent to become
statistically significant, four to five orders of magnitude have to
be spanned by extrapolation (Figure 1).
In this 'commentary', different mechanisms of carcinogenic
action will be discussed with respect to the shape of the dose —
response curve. Special emphasis will be given to the aspect of
linear versus non-linear relationships and to the possibilities of
thresholds, i.e. true no-effect doses (1). Non-linearities strongly
affect the estimation of 'virtually safe' dose levels: if a linear
extrapolation from a high-dose point to dose zero is made in a
sublinear situation, the risk from exposure to low doses is
overestimated, and vice versa (see Figure 2, top chart, for
definitions).
The only variable discussed will be the dose. It would be
beyond the scope of this analysis to introduce aspects of time
or latency and dose-dependent shifts of target organs. Further-
more, chronic exposure and a fixed period of observation will
be assumed.
The multi-stage genetic nature of carcinogenesis
The incidence of a number of human cancers rises sharply with
age. For stomach and lung, for instance, age-specific tumor
incidence rates increase exponentially with age, with exponents
of 4—7 for ages between 30 and 65 years. This time —incidence
curve is in line with a multi-step process for carcinogenesis
requiring 4—7 independent 'events' (2). Because of the heritable
nature of cancer, these 'events' are most probably genetic
changes. Tumor development in the human colon, for example,
appears to require more than one type of genetic change for
malignant transformation. These include hypomethylation, gene
mutations, recombinations and chromosomal aberrations (3).
Some of these changes represent true DNA damage, while others
are constitutive processes regulating gene expression. For both
aspects, experimental evidence and theoretical considerations will
be discussed as far as they affect the dose-response relationships.
Dose response for genotoxk carcinogens
DNA adduct formation as a function of dose
The formation of covalent DNA-carcinogen adducts is a
common activity of a large number of chemical carcinogens,
including the majority of the known organic human carcinogens.
The formation of DNA adducts has been used as a quantitative
indicator of carcinogenicity of genotoxic compounds in animals
(4).
The data on dose —response relationships have been reviewed
before (5 — 7). It emerged that in the lowest dose range the rate
of all processes is proportional to the concentration of substrate,
generating a linear dose —response curve (Figure 2, top chart).
At higher concentrations, many possibilities for non-linearities
become apparent (7). These include the saturation or induction
of enzymes involved in either metabolic activation and inactiva-
tion of the substrate or in DNA repair (Figure 2, top chart). The
sublinear dose - response relationships observed with form-
aldehyde (7) (saturation of the inactivation with glutathione) and
methylating agents (6) (saturation of (Amethylguanine repair)
or the superlinear shapes seen with vinyl chloride (Figure 1) and
aflatoxin B| (6) (saturation of the activation pathway) or with
the tobacco-specific nitroso compound NNK (7) ('dangerous'
low-AfM pathway leading to adducts) can all be explained on this
basis.
Metabolic activation and inactivation
The enzymatic activation of carcinogens to the ultimate electro-
philic metabolite and its detoxification could be modeled
mathematically, if the kinetics of all enzymatic and non-enzymatic
processes were known (8). With more kinetic parameters becom-
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Fig. 1. Dose-response relationship for tumor induction by formaldehyde
(FA) and vinyl chloride (VC), snowing ranges of experimental observation
and extrapolation. Note: In the double-log plot chosen, proportionality
between dose and incidence generates a line of 45° angle (slope = 1; lower
part for VC). Higher slopes (slope ~ 4 for FA) indicate an exponential
behavior.
ing available in both animals and humans, this type of pharmaco-
kinetic modeling might become a valuable tool, especially for
comparisons among different animal species (9) and for the
prediction of dose-response relationships.
In contrast to the above models based on enzyme kinetics,
Cornfield (10) has presented a theoretical concept that is often
over-interpreted to state that enzymatic activation and inactivation
pathways can generate a true no-effect level. This is not the case.
The model produces a thresholded dose—response curve (shaped
like a hockey stick) under the assumption of an irreversible
protection reaction with indefinitely high rate. This implies that
the rate of DNA binding is zero as long as 'toxin-deactivator'
is available. This situation is unrealistic for competitive enzymatic
and chemical reactions.
Genetic changes as a function of DNA adduct levels
DNA adducts alone are not sufficient to generate heritable genetic
changes because adducts themselves are not copied onto the
progeny DNA strands. DNA replication can, however, lead to
mutations in the new strand opposite an adduct. If this occurs
in a critical gene, the daughter cell could form the origin of a
transformed cell clone. Since DNA adducts can be repaired (with
varying efficiency), the probability of a DNA adduct becoming
fixed as a genetic change is dependent on the relative rates of
DNA repair and cell division. Any process that accelerates the
rate of cell division will therefore have a synergistic effect on
the formation of mutations (and tumor incidence).
High levels of DNA adducts can lead to cell death and
regenerative hyperplasia in the surrounding tissue. The acceler-
ated cell division in the surviving cells can result in an increased
probability of genetic changes due to its own adducts. The higher
rate of fixing the DNA damage in the form of a mutation will
result in a sublinear shape of the dose —response curve in the
cytotoxic dose range (Figure 2, middle chart). Below cytotoxic
doses, the shape of the dose-response curve is governed by the
level of the DNA damage alone and can be linear.
A nice example for such a linear — sublinear shape can be
given for the induction of liver tumors in female rats by nitroso-
diethylamine. In this study (11), nitrosodiethylamine was
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Fig. 2. Schematic representation of the dose-effect relationship for three
consecutive aspects of tumor induction by genotoxic agents.
administered in the drinking water to groups of 60 rats at 15 dose
levels (0.033-16.9 p.p.m.). When the ratio observed/expected
liver cancer incidence is plotted as a function of dose, a quadratic
to cubic shape is seen. However, if only die low-dose data are
taken (up to 0.5 p.p.m.), the increase in tumor response appears
to be linear with dose and less rapid than the curve fitted to all
data points (12). This large experiment, using > 1000 animals,
afforded a unique opportunity to detect linearity at low dose levels
and a power of the dose in the high-dose range, and is a good
example to stress the idea that mode of action and potency of
a carcinogen can change with the dose level.
The highest dose level used in a standard bioassay on carcino-
genicity is normally chosen as the maximum tolerated dose that
is expected to produce slight signs of toxicity (13). In view of
the importance of sustained hyperplasia in carcinogenesis, a
sublinear dose—response relationship even with genotoxic
carcinogens is no longer surprising.
Superposition of the dose—response curves for two genetic
changes
As a consequence of the multi-stage nature of carcinogenesis,
the probability, P, of cancer induction can be approximated by
the product of the probabilities for the various steps (2). Since
all steps must have a genetic basis to become heritable, DNA-
damaging compounds can accelerate more than one step. The
dose—response relationship then appears as a product of the
curves for the individual steps. If, for instance, two events are
affected, both proportionally with the level of DNA adducts, the
product of the lines will be exponential (Figure 2, bottom chart).
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Summary for genotoxic carcinogens
The formation of DNA adducts is proportional to dose as long
as the concentrations of the carcinogen and of its proximate and
ultimate form(s) are below the KM values of the enzymes
involved. At higher dose levels, saturation and induction of
enzymatic processes often generate non-linear shapes. In addition,
the correlation of the level of DNA adducts with the rate of
genetic changes shows a non-linearity as soon as regenerative
hyperplasia accelerates the fixation of the DNA lesion in the form
of a mutation. Finally, an exponential relationship between DNA
adduct level and tumor incidence is expected if the DNA adducts
accelerate more than one step of the process of carcinogenesis.
The three aspects are combined in Figure 2, which illustrates
that non-linear parts in the dose —response relationships are the
rule rather than the exception for genotoxic carcinogens.
Dose response for epigenetic carcinogens
Definitions
A cancer cell expresses genes that allow autonomous and invasive
growth. From a cellular point of view, a cancer cell is a very
healthy one. Its various functions can all be useful at some time
and are probably expressed individually under specific conditions
of differentiation. A cancer cell apparently expresses a combina-
tion of these functions at an inappropriate time. The process of
malignant transformation is therefore not necessarily dependent
on gene mutations but can include normal gene regulation. The
process of carcinogenesis could thus be called 'epigenetic' if it
involves only constitutive genes and mechanisms of expression
available also to normal stem cells.
Although every effort is being made to identify the set of genes
that must be turned on or off for the expression of the malignant
phenorype, this goal has not yet been reached (14). Most
examples given below are therefore based on the stimulation of
cell division rather than of maldifferentiation.
Sustained hyperplasia appears to be a necessary (but not
sufficient?) condition for tumor promotion and progression
(15,16). It appears that a stem cell maximally stimulated to divide
can fix this differentiation stage permanently after a certain period
of time. Stimulated cell division also entails an aspect of
genotoxicity because it accelerates the fixation of DNA lesions
from endogenous genotoxic agents and processes (17,18). This
indirect type of genotoxicity will not be considered, however,
for the following discussion of the dose-response curve expected
for epigenetic processes.
Dose response for a single cell
A cell either divides (or differentiates) or it does not. Therefore,
if a chemical stimulates cell division or (mal)differentiation, the
dose-response relationship can only be a 'switch' function
resulting in a true thresholded curve (Figure 3, top).
Dose response in a cell population
In a cell population, individual cells will differ with respect to
their sensitivity to the driving force. This smoothes the edges
of the thresholded curve, if the fraction of responding cells is
plotted as a function of dose. Furthermore, we can assume that
a small number of cells divide or differentiate in the absence of
the exogenous agent, as a result of an endogenous background
process replacing unavoidably lost cells. In the lowest dose range
of an exogenous carcinogen, this idea leads to two possibilities
for the dose — response relationship.
Linear low-dose response. If the carcinogen acts competitively
with the endogenous driving force, even a single carcinogen
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Fig. 3. Possible shapes of dose—response curves for carcinogens that affect
the rate of cell division or maldifferentiation. Top, situation for single cell;
middle, situation with cell population and endogenous process accelerated
by carcinogen; bottom, situation with cell population and new process
initiated by carcinogen.
molecule could recruit one additional cell for division or
maldifferentiation (Figure 3, middle). Such a hormone-like effect
of the exogenous compound would be proportional to dose in
the lowest range. Tumor induction by estrogenic compounds or
2,3,7,8-tetrachlorodibenzo-/Mlioxin could fall into this category.
Thresholded low-dose response. If, on the other hand, the
carcinogen affects cell division and differentiation by a
mechanism that has no endogenous counterpart, the dose response
can even include a true no-effect level. This situation could, for
example, be encountered when high concentrations of a
compound in the urinary tract lead to crystal formation. If local
irritation, inflammation, and regenerative hyperplasia represent
the epigenetic stimulus required for an accelerated malignant
transformation, no effect will be seen at all below the saturation
concentration. The result is a true thresholded situation (Figure 3,
bottom).
Summary for epigenetic carcinogens
The common dose—response relationship for epigenetic carcino-
gens appears to be non-linear. Whether a true threshold can be
postulated or whether a linear low-dose response operates,
depends on the absence or presence of an endogenous activity
that is competitively acted upon by the exogenous agent.
Dose response for tumor induction
The mechanistic analysis given above indicated a large number
of possibilities for non-linear dose —response relationships both
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for genotoxic and epigenetic aspects of carcinogenesis, especially
at high exposure levels. In this dose range, data on tumor
formation in animals and humans are also available. The
following paragraphs will show whether the postulated steep
slopes are indeed found.
Bioassays on carcinogenicity
A comprehensive and recent review on this topic is available (12).
In the observable (high) dose range used in animal studies, several
examples from large, well-documented studies suggest that non-
linearities are common. For instance, a sublinear curve is seen
for bladder cancer caused by sodium saccharin and 2-acetyl-
aminofluorene, for liver cancer induced by diethylnitrosamine
and dimethylnitrosamine, and for esophageal cancer from diethyl-
nitrosamine. In an extreme case, formaldehyde induced nasal
tumors in rats with a frequency of 1 and 44% after inhalation
exposures of 5.6 and 14.3 p.p.m. respectively (see Figure 1)
(19,20). Here, the tumor incidence increased with the fourth
power of the dose. In all other examples, the respective exponent
was not larger than two.
If a proposed non-linearity is to be used for a low-dose risk
extrapolation, the slope and range of the non-linearity must be
investigated with relevant biological end-points, such as DNA
adduct level, level of sustained hyperplasia and activation of
oncogenes. In the absence of such information, a linear extrapol-
ation of tumor incidence from the lowest reliable data point to
the spontaneous rate has been proposed for all classes of
carcinogens (21,22).
Epidemiological evidence in humans
In human studies, significant deviations from linearity are much
more difficult to find. Only in two reports, namely lung cancer
in smoking British physicians and bladder cancer from
/?-naphthylamine exposure, is a sublinear fit clearly better than
a linear one. The relationship in these two cases is approximately
quadratic; higher exponents have not been observed (12).
The fourth power of the dose seen in an animal experiment
is clearly compatible with the mechanistic analysis discussed
above. Astonishing at first glance is the fact that epidemiological
investigations with humans in general showed a linear
dose-response relationship, or, at most, a second order for the
dose. One possible reason for a systematic underestimation of
the exponent of dose in human studies could be error in dose
measurement. Both underestimation of the dose in the high-dose
range and overestimation in the low-dose range would result in
a flattening of the shape of the dose-response curve. Another
explanation for the observed difference between animals and
humans might be the heterogeneity of the human population. This
idea will be discussed below.
Linearized dose — response relationship in a heterogeneous
population
So far, carcinogenesis has been discussed mechanistically, as a
process in one individual or in a relatively homogeneous animal
population. The relationships between dose and effect have been
analyzed as though we could repeatedly test increasing doses of
the carcinogen in the same animal. The epidemiological evidence
with humans, however, is based on a highly heterogeneous
population. Interindividual differences in the metabolism of
chemical carcinogens and in repair rates of DNA adducts, for
instance, are large and reflect acquired and inherited host factors
that may influence an individual's risk for development of cancer
(23). As an example, genetically controlled metabolic capacities
appear to affect the sensitivity of humans to develop bladder
cancer (24).
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The effect of population heterogeneity on the dose — response
relationship for tumor induction would follow the same rules as
discussed above for the maldifferentiation of a single cell versus
a cell population (Figure 3). While a completely homogeneous
population of individuals would show an indefinitely steep slope
at one point in the dose —response curve (in analogy to the top
chart of Figure 3), heterogeneity will systematically reduce the
slope.
Heterogeneity is due to both genetic and life-style factors.
Under the preliminary assumption that only one genetic factor,
combined with a small number of less important life-style factors,
modulate the sensitivity of an individual to a chemical carcinogen,
the population could be separated into a population A where a
given dose leads to a tumor in almost all exposed individuals,
whereas the remaining people (population B) develop a tumor
only at higher dose levels (Figure 4, top). More realistic is the
situation where the sensitivity is governed by a number of genes:
the dose -response curve becomes flatter with each modulatory
factor (Figure 4, middle). When the number of factors is
increased ad infinitum, linearity results between the 'spontaneous'
tumor incidence and the high-dose incidence (Figure 4, bottom).
Although this situation cannot be reached in reality, the linearizing
effect of population heterogeneity might be sufficiently strong
to account for the fact that dose — response curves in most human
epidemiological studies do not show significant deviation from
linearity.
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Fig. 4. Schematic representation of dose-effect relationships in
heterogeneous populations. From top to bottom the number of genetic and
life-style factors affecting the sensitivity to a chemical carcinogen increases.
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Conclusions
The foregoing analysis has revealed a large number of
mechanisms that generate non-linear parts in the dose-response
curve in a homogeneous population. Lowest-dose linearity
depends on whether an endogenous process of carcinogenesis is
accelerated by the carcinogen. This holds both for genotoxic
agents and epigenetic carcinogens.
In a heterogeneous population such as humans, non-linear
shapes of the dose — response curve are linearized by the presence
of genetic and life-style factors that affect the sensitivity for the
development of cancer. The level of linearization depends on the
number of modulating factors for a given carcinogen: for
carcinogens forming DNA adducts by enzymatic activation, this
number is probably higher than for an epigenetic carcinogen with
a highly specific, hormone-like mode of action.
For risk assessment in a heterogeneous population, therefore,
linear extrapolation from the high-dose incidence to the control
rate has to be taken into consideration even if the mechanism
of action would result in a non-linear shape of the dose—response
curve in a homogeneous population.
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